 |
September 4, 2007
Big Pharma breaking R & D promise to Canadians: federal drug watchdog
20-year anniversary of controversial patent law changes shows little gain for Canadians |
|
| Twenty years after the federal government increased market monopolies for brand-name drug companies, a report form the federal government’s drug watchdog shows that, for the sixth consecutive year, Big Pharma is breaking its commitment to spend at least 10 percent of its sales revenue on research and development in Canada. | read more... |
|
May 15, 2007
Ontario, Quebec Have Lowest Generic Usage, Highest Per Capita Drug Spend
Generic Drug Makers Offer 60 per cent Solution to Rising Rx Drug Costs |
|
| The two provinces with the lowest levels of generic drug use in Canada also have the highest per capita spending on prescription drugs, the Canadian Generic Pharmaceutical Association (CGPA) said today in response to figures released by the Canadian Institute for Health Information (CIHI) in its annual report on drug spending. | read more... |
|
March 21, 2007
Generic Drug Makers Propose 60% Solution to Rising Rx Drug Costs
Increasing use of generic drugs to U.S. levels would save $700-million |
|
| Canadians could save $700-million on the cost of prescription medicines in the first year alone if the use of generic drugs increased to levels in the United Sates, the Canadian Generic Pharmaceutical Association (CGPA) said today following the release of 2006 Canadian prescription drug sales information by IMS Health Canada. | read more... |
|
February 16 , 2007
Canada’s Generic Pharmaceutical Industry Congratulates
HPIC on Opening of Distribution Centre
Generic Industry Donates 100 million doses of medicine in 2006 |
|
| The following are remarks by Jim, Keon, President of the Canadian Generic Pharmaceutical Association, at today’s official opening of the Health Partners International Canada (HPIC) Distribution Centre. | read more... |
|
January 15, 2007
Allan Oberman Elected Chair of Canadian Generic Pharmaceutical Association
|
|
| The Canadian Generic Pharmaceutical Association (CGPA) is pleased to announce the election of Allan Oberman, President and Chief Executive Officer of Novopharm, as Chair of CGPA. | read more... |
|
| < back to news index |
|
TOP |
| |
|
|
